drugset / Trial / NCT00719381
Effect of Pioglitazone on Inflammation in Cystic Fibrosis
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effect of pioglitazone on reducing airway inflammation in cystic fibrosis and characterize the amount and timecourse of pioglitazone elimination from the body.
Timeline
- Start
- 2008-01
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pioglitazone | Small molecule | 30 mg | — |